sellNotable cluster of 2
James F Oliviero III sold $3.1M of CKPT
CEO, President and Director at Checkpoint Therapeutics, Inc.. 822,397 shares at an average of $3.74, traded Dec 18, 2024, filed Dec 20, 2024.
Warning score
63Value
$3.1M
822,397 shares
Holdings after
3,194,583
-20% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$3.1M at market
- +5Share of holdings soldSold 20% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-130963, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | SOpen-market sale COMMON STOCK | -602,167 | $3.87 | $2.3M | 3,414,813 | Dec 20, 2024 |
| Dec 19, 2024 | SOpen-market sale COMMON STOCK | -220,230 | $3.38 | $744k | 3,194,583 | Dec 20, 2024 |
| Dec 20, 2024 | GGift COMMON STOCK | -900,000 | $0.00 | $0 | 2,294,583 | Dec 20, 2024 |
Related signals
Other insiders at Checkpoint Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | CKPTsell Checkpoint Therapeutics, Inc. | Fortress Biotech, Inc. owner | $129k 100,000 shares | -2% | |
| 37Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $50k 12,322 shares | -1% | |
| 40Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $61k 15,090 shares | -0% | |
| 41Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $64k 19,564 shares | -1% | |
| 43Moderate | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $272k 74,110 shares | -5% | |
| 60Notable | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $1.1M 268,432 shares | -21% | |
| 35Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $27k 13,038 shares | -2% | |
| 40Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $50k 24,610 shares | -1% | |
| 30Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $4,212 2,035 shares | -1% | |
| 33Weak | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $12k 5,894 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.